p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma

被引:53
|
作者
Fujimoto, A [1 ]
Morita, R [1 ]
Hatta, N [1 ]
Takehara, K [1 ]
Takata, M [1 ]
机构
[1] Kanazawa Univ, Sch Med, Dept Dermatol, Kanazawa, Ishikawa 9208641, Japan
关键词
loss of heterozygosity; microsatellites; gene mutation; tumour suppressor gene; immunohistochemistry;
D O I
10.1038/sj.onc.1202803
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In an attempt to examine whether the inactivation of p16(INK4a) is an important early event in the development of sporadic melanoma in vivo, we have systematically analysed 46 uncultured primary cutaneous melanomas, Loss of heterozygosity (LOH) of chromosome region 9p21-22 (where the p16(INK4a) resides) was detected in II tumours (24%) by PCR-based LOH analyses. Direct sequencing of all three exons of the p16(INK4a) gene in these 11 tumours revealed no somatic mutation although germline mutations which have not been reported previously as common polymorphisms were detected in two patients. Further sequencing analyses of the p16(INK4a) gene exon 2 in 19 additional tumours with no evidence of LOH on 9p21-22 identified only one heterozygous C->T mutation at codon 81 altering a proline to a leucine. A sensitive methylation-specific PCR assay did not reveal ne novo methylation of the 5'CpG island in exon 1 of the p16(INK4a) gene in any of the tumours showing 9p21-22 allelic loss or a heterozygous p16(INK4a) mutation. Complete loss of p16(INK4a) protein, most likely due to homozygous deletion of the p16(INK4a) gene, was observed in 6 (15%) out of 39 evaluable cases by immunohistochemical analyses on frozen sections using two different anti-p16(INK4a) antibodies. The results show that inactivation of p16(INK4a) is not as frequent in primary melanoma as has been reported in cell lines, and warrant further search for another tumour suppressor on 9p21-22. This study also emphasizes the importance of examining uncultured primary tumours rather than cell lines to define early events in tumorigenesis.
引用
收藏
页码:2527 / 2532
页数:6
相关论文
共 50 条
  • [31] Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
    Krimpenfort, P
    Quon, KC
    Mooi, WJ
    Loonstra, A
    Berns, A
    NATURE, 2001, 413 (6851) : 83 - 86
  • [32] Frequent alterations of the p14ARF and p16INK4a genes in primary central nervous system lymphomas
    Nakamura, M
    Sakaki, T
    Hashimoto, H
    Nakase, H
    Ishida, E
    Shimada, K
    Konishi, N
    CANCER RESEARCH, 2001, 61 (17) : 6335 - 6339
  • [33] Infrequent mutation of p16(INK4) in sporadic melanoma
    Healy, E
    Sikkink, S
    Rees, JL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 318 - 321
  • [34] Reciprocal p16INK4a inactivation and retinoblastoma expression in colorectal carcinoma.
    Lemass, HC
    Ryan, E
    MadMathuna, P
    Crowe, J
    O'Keane, JC
    GASTROENTEROLOGY, 2000, 118 (04) : A49 - A49
  • [35] Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms
    Silva, J
    Silva, JM
    Domínguez, G
    García, JM
    Cantos, B
    Rodríguez, R
    Larrondo, FJ
    Provencio, M
    España, P
    Bonilla, F
    JOURNAL OF PATHOLOGY, 2003, 199 (03): : 289 - 297
  • [36] Radionuclides in cigarettes may lead to carcinogenesis via p16INK4a inactivation
    Prueitt, Robyn L.
    Goodman, Julie E.
    Valberg, Peter A.
    JOURNAL OF ENVIRONMENTAL RADIOACTIVITY, 2009, 100 (02) : 157 - 161
  • [37] p16INK4a inactivation is not required to immortalize human mammary epithelial cells
    Herbert, BS
    Wright, WE
    Shay, JW
    ONCOGENE, 2002, 21 (51) : 7897 - 7900
  • [38] p16INK4a inactivation is not required to immortalize human mammary epithelial cells
    Brittney-Shea Herbert
    Woodring E Wright
    Jerry W Shay
    Oncogene, 2002, 21 : 7897 - 7900
  • [39] p16INK4a Expression in Porokeratosis
    Uryu, Miki
    Furue, Masutaka
    ANNALS OF DERMATOLOGY, 2017, 29 (03) : 373 - 376
  • [40] P16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholanglocarcinoma
    Taniai, M
    Higuchi, H
    Burgart, LJ
    Gores, GJ
    GASTROENTEROLOGY, 2002, 123 (04) : 1090 - 1098